The global anesthesia and respiratory devices market size is estimated to reach USD 75.9 billion by 2030, registering a CAGR of 5.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of respiratory diseases, patient preferences for a reduced hospital stay and supportive government funding are among the key driving factors. Furthermore, aging is considered one of the greatest risk factors for the development of sleep apnea disorders and is, therefore, expected to be a high-impact rendering driver for this industry. The COVID-19 pandemic had a significant impact on the industry. Different segments were impacted differently. For instance, the ventilators segment witnessed exponential growth owing to the sudden surge in the demand for mechanical ventilators.
However, this demand decreased post-2021, wherein the industry size decreased dramatically. Concerning the nebulizers segment, people were apprehensive to use nebulizers owing to the use of inhaled medications, which are considered a potential source of viral transmission and immunosuppression, which restricted the growth, but did not negatively impact the industry. Shifting the preference of patients towards reduced hospital stay is anticipated to increase the adoption of anesthesia and breathing instruments, thereby, driving the market. As per the American Hospital Association, approximately 20% of Medicare beneficiaries, when discharged from the hospital return within 30 days. Identifying and reducing avoidable readmissions is expected to improve healthcare safety and reduce spending.
Hence, policymakers are striving to reduce the hospital stays of patients. In the Patient Protection and Affordable Act, Congress initiated the Hospital Readmission Reduction Program (HRRP), under which, Medicare is allowed to penalize hospitals for higher rates of readmissions since 2013. Due to the implementation of this act, many physicians and patients opt for anesthesia and breathing devices, such as ambulatory infusion pumps and home respiratory monitors. Key players are taking initiatives to develop advanced instruments to bring improvement in the treatment. For instance, in May 2022, Max Ventilator launched Non-Invasive (NIV) ventilators consisting of inbuilt humidifiers and oxygen therapy. The device is user-friendly as well as lightweight and is also priced lower than the traditional ventilators. Such initiatives are anticipated to propel industry growth in the coming years.
Request a free sample copy or view report summary: Anesthesia And Respiratory Devices Market Report
In terms of revenue, the respiratory devices segment held the largest revenue share in 2024, owing to the rising prevalence of Chronic Obstructive Pulmonary Disease (COPD), asthma, and tuberculosis, among others
The anesthesia devices segment is expected to grow significantly over the forecast period, owing to the rising number of surgeries and various technological advancements by market players
North America accounted for the largest revenue share in 2024 owing to the presence of major players in the region
Asia Pacific is expected to witness the fastest CAGR during the forecast period owing to increasing healthcare expenditure and awareness among patients.
Grand View Research has segmented the global anesthesia and respiratory devices market based on product, and region:
Anesthesia and Respiratory Devices Product Outlook (Revenue, USD Million, 2018 - 2030)
Respiratory Devices
Respiratory Equipment
Humidifiers
Heat Humidifiers
Heated Wire Breathing Circuits
Heat Exchangers
Pass Over Humidifiers
Nebulizers
Pneumatic Nebulizers
Mesh Nebulizers
Ultrasonic Nebulizers
Oxygen Concentrator
Fixed Oxygen Concentrators
Portable Oxygen Concentrators
Positive Airway Pressure Devices
Bilevel & automatic positive airway pressure devices
Continuous positive airway pressure devices
Reusable Resuscitators
Ventilators
Adult Ventilators
Neonatal Ventilators
Respiratory Inhalers
Dry Powdered Inhalers
Metered Dose Inhaler
Respiratory Disposables
Disposable Oxygen Masks
Resuscitators
Tracheostomy Tubes
Oxygen Cannula
Respiratory Measurement Devices
Pulse Oximetry systems
Capnographs
Spirometers
Peak Flowmeters
Anesthesia Devices
Anesthesia Machines
Anesthesia Workstation
Anesthesia delivery machines
Portable
Standalone
Anesthesia Ventilators
Anesthesia Monitors
Anesthesia Disposables
Anesthesia Masks
Anesthesia Accessories
Anesthesia and Respiratory Devices ???????Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Anesthesia And Respiratory Devices Market
General Electric Company
Medtronic
Teleflex Incorporated
Koninklijke Philips N.V.
Drägerwerk AG & Co. KGaA
Getinge AB.
Smiths Group plc
Fisher & Paykel Healthcare Limited.
Masimo
B. Braun Melsungen AG
ResMed
Shenzhen Mindray Bio-Medical Electronics Co., Ltd
Inogen, Inc.
Caire Medical (a subsidiary of NGK Spark Plug),
DeVilbiss Healthcare (a subsidiary of Drive Medical).
React Health (Respiratory Product Line from Invacare Corporation)
O2 Concepts
Nidek Medical Products, Inc.
Omron Corporation
GE Healthcare
Allied Healthcare
Vectura Group Plc.
PARI Respiratory Equipment, Inc.
Aerogen
DeVilbiss Healthcare LLC
Briggs Healthcare
Beurer GmBH
"The quality of research they have done for us has been excellent..."